Vitrolife AB (OSTO:VITR) Total Stockholders Equity : kr13,231 Mil (As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Vitrolife AB Total Stockholders Equity?

Vitrolife AB's Total Stockholders Equity for the quarter that ended in Mar. 2024 was kr13,231 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Vitrolife AB's Book Value per Share for the quarter that ended in Mar. 2024 was kr97.68. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Vitrolife AB's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.16.

Vitrolife AB Total Stockholders Equity Historical Data

The historical data trend for Vitrolife AB's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vitrolife AB Total Stockholders Equity Chart

Vitrolife AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

1,794.02

2,012.57

15,322.00

16,736.00

12,722.00

Vitrolife AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															17,013.00	17,677.00	17,430.00	12,722.00	13,231.00

Vitrolife AB (OSTO:VITR) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Vitrolife AB's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(13231	-	0)	/	135.447
	=	97.68

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Vitrolife AB's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(119	+	1951)	/	13231
	=	0.16

Vitrolife AB Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Vitrolife AB's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Vitrolife AB (OSTO:VITR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vitrolife AB (OSTO:VITR) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

0YAY:UK VTFN:Germany

Address

Box 9080, Gothenburg, SWE, 400 92

Website

https://www.vitrolife.com

Vitrolife AB provides medical devices and genetic testing services intended for the reproductive-health market in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics (in vitro fertilization) in enhancing their practice as well as the outcome of a patient's fertility treatment, thereby enabling patients to receive advanced support to navigate the complexities of reproductive health through successful outcomes and patient satisfaction.

Vitrolife AB (OSTO:VITR) Headlines

No Headlines